Table II.
A, Biological processes | |||
---|---|---|---|
Term | Function | Count | P-value |
GO:0048666 | Neuron development | 20 | 1.10×10-4 |
GO:0030182 | Neuron differentiation | 22 | 4.20×10−4 |
GO:0042127 | Regulation of cell proliferation | 32 | 6.13×10-4 |
GO:0045197 | Establishment or maintenance of epithelial cell apical/basal polarity | 4 | 7.15×10−4 |
GO:0044057 | Regulation of system process | 17 | 9.04×10-4 |
B, Cellular components | |||
Term | Function | Count | P-value |
GO:0044459 | Plasma membrane part | 72 | 3.26×10−5 |
GO:0005886 | Plasma membrane | 107 | 7.61×10-5 |
GO:0005911 | Cell-cell junction | 12 | 1.82×10−3 |
GO:0031965 | Nuclear membrane | 7 | 3.72×10-3 |
GO:0030054 | Cell junction | 21 | 4.78×10−3 |
C, Molecular function | |||
Term | Function | Count | P-value |
GO:0019904 | Protein domain specific binding | 18 | 1.00×10-3 |
GO:0003707 | Steroid hormone receptor activity | 6 | 4.20×10−3 |
GO:0004879 | Ligand-dependent nuclear receptor activity | 6 | 8.61×10-3 |
GO:0016247 | Channel regulator activity | 6 | 9.24×10−3 |
GO:0005249 | Voltage-gated potassium channel activity | 7 | 2.24×10-2 |
D, KEGG pathways | |||
Term | Function | Count | P-value |
hsa05200 | Pathways in cancer | 19 | 5.37×10−4 |
hsa04360 | Axon guidance | 10 | 3.02×10-3 |
hsa04720 | Long-term potentiation | 7 | 4.86×10−3 |
hsa05211 | Renal cell carcinoma | 7 | 5.60×10-3 |
hsa05223 | Non-small cell lung cancer | 6 | 8.18×10−3 |
E, REACTOME pathways | |||
Term | Function | Count | P-value |
REACT_9417 | Signaling by epidermal growth factor receptor | 6 | 4.27×10-3 |
REACT_11061 | Signaling by nerve growth factor | 11 | 6.89×10−3 |
GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.